Sort by 'shares'
Multiple Myeloma: Minimal Residual Disease Testing as an End Point Treatment
Most multiple myeloma patients, even those in complete response, may show signs of relapse at some point of time. So, testing and quantifying Minimal Residual Disease (MRD) has become essential to obtain better prognostic correlations. Researchers believe that MRD testing…
The MMRF Precision Medicine Model – How Close to Multiple Myeloma Cure Are We?
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated pillars fueled by data generation and integration; collaboration and discovery; and accelerating clinical trials. Integrating this model…
High Risk Pregnancies – Causes and Care
A high risk pregnancy can be life-threatening to the mother as well as the baby. Women must be trained to tell, when they need medical attention themselves, in addition to the baby care training they receive. We are talking to…
Living well with Prostate Cancer – Part 2
We continue our discussion with Dr. Paul Schellhammer on prostate cancer and life thereafter. The prostate cancer panel led by Mike Scott will address how patients/advocates/caregivers can help the medical community develop new data that will provide better information on…
Precision Medicine: Identifying Targeted Cancer Treatments with Genomic Testing
Precision, or personalized, medicine has made a sea-change in cancer treatment. A pipe dream for most patients 10 years ago, it is a reality today. Precision Medicine's keystone is the ability to identify personal gene characteristics and match them to…